Matrix metalloproteinases in platelet function: Coming of age

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 3, 2008, Pages 514-516

  Santos Martinez, M J ^a   Medina, C ^a   Gilmer, J F ^a   Radomski, Mark W ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ALPHA2 INTEGRIN; BETA3 INTEGRIN; DOXYCYCLINE HYCLATE; FIBRINOGEN; GELATINASE A; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITOR; PADGEM PROTEIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; VERY LATE ACTIVATION ANTIGEN 5;

CELL INTERACTION; CLINICAL TRIAL; ENZYME ACTIVATION; ENZYME BINDING; HUMAN; NOTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE;

BLOOD PLATELETS; FIBRINOGEN; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTEGRIN ALPHA5BETA1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; MODELS, BIOLOGICAL; P-SELECTIN; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

EID: 39549104947     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02876.x     Document Type: Note

References (28)

1. Sawicki G, Salas E, Murat J, Miszta-Lane H, Radomski MW. Release of gelatinase A during platelet activation mediates aggregation. Nature 1997; 386: 616-9.
2. Needleman P, Moncada S, Bunting S, Vane JR, Hamberg M, Samuelsson B. Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature 1976; 261: 558-60.
3. Born GV. Effects of adenosine diphosphate (ADP) and related substances on the adhesiveness of platelets in vitro and in vivo. Br J Haematol 1966; 12: 37-8.
4. Sawicki G, Sanders EJ, Salas E, Wozniak M, Rodrigo J, Radomski MW. Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost 1998; 80: 836-9.
5. Radomski A, Stewart MW, Jurasz P, Radomski MW. Pharmacological characteristics of solid-phase von Willebrand factor in human platelets. Br J Pharmacol 2001; 134: 1013-20.
6. Martinez A, Salas E, Radomski A, Radomski MW. Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: Interactions with nitric oxide. Med Sci Monit 2001; 7: 646-51.
7. Kazes I, Elalamy I, Sraer JD, Hatmi M, Nguyen G. Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: Involvement in MMP2 activation and platelet aggregation. Blood 2000; 96: 3064-9.
8. Falcinelli E, Guglielmini G, Torti M, Gresele P. Intraplatelet signaling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation. J Thromb Haemost 2005; 3: 2526-35.
9. Falcinelli E, Giannini S, Boschetti E, Gresele P. Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: Lack of inhibition by aspirin. Br J Haematol 2007; 138: 221-30.
10. Jurasz P, Sawicki G, Duszyk M, Sawicka J, Miranda C, Mayers I, Radomski MW. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: Regulation by nitric oxide. Cancer Res 2001; 61: 376-82.
11. Alonso-Escolano D, Strongin AY, Chung AW, Deryugina EI, Radomski MW. Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: Role of receptor glycoproteins. Br J Pharmacol 2004; 141: 241-52.
12. Medina C, Jurasz P, Santos-Martinez MJ, Jeong SS, Mitsky T, Chen R, Radomski MW. Platelet aggregation-induced by caco-2 cells: Regulation by matrix metalloproteinase-2 and adenosine diphosphate. J Pharmacol Exp Ther 2006; 317: 739-45.
13. Jurasz P, North S, Venner P, Radomski MW. Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: A preliminary study. Thromb Res 2003; 112: 59-64.
14. Jurasz P, Alonso-Escolano D, Radomski MW. Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol 2004; 143: 819-26.
15. Alonso-Escolano D, Medina C, Cieslik K, Radomski A, Jurasz P, Santos-Martinez MJ, Jiffar T, Ruvolo P, Radomski M. PKC{delt} mediates platelet-induced breast cancer cell invasion. J Pharmacol Exp Ther 2006; 318: 373-80.
16. Fernandez-Patron C, Martinez-Cuesta MA, Salas E, Sawicki G, Wozniak M, Radomski MW, Davidge ST. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb Haemost 1999; 82: 1730-5.
17. Sheu JR, Fong TH, Liu CM, Shen MY, Chen TL, Chang Y, Lu MS, Hsiao G. Expression of matrix metalloproteinase-9 in human platelets: Regulation of platelet activation in in vitro and in vivo studies. Br J Pharmacol 2004; 143: 193-201.
18. Galt SW, Lindemann S, Allen L, Medd DJ, Falk JM, McIntyre TM, Prescott SM, Kraiss LW, Zimmerman GA, Weyrich AS. Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circ Res (Online) 2002; 90: 1093-9.
19. Colciaghi F BB, Pastorino L, Marcello E, Zimmermann M, Cattabeni F, Padovani A, Di Luca M. [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med 2002; 8: 67-74.
20. Gardiner EE, Karunakaran D, Shen Y, Arthur JF, Andrews RK, Berndt MC. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost 2007; 5: 1530-7.
21. Bergmeier W, Piffath CL, Cheng G, Dole VS, Zhang Y, von Andrian UH, Wagner DD. Tumor necrosis factor-{alpha}-converting enzyme (ADAM17) mediates gpib{alpha} shedding from platelets in vitro and in vivo. Circ Res 2004; 95: 677-83.
22. Rabie T, Strehl A, Ludwig A, Nieswandt B. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem 2005; 280: 14462-8.
23. Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 2001; 98: 1662-6.
24. Radomski A, Jurasz P, Sanders EJ, Overall CM, Bigg HF, Edwards DR, Radomski MW. Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets. Br J Pharmacol 2002; 137: 1330-8.
25. Murate T, Yamashita K, Isogai C, Suzuki H, Ichihara M, Hatano S, Nakahara Y, Kinoshita T, Nagasaka T, Yoshida S, Komatsu N, Miura Y, Hotta T, Fujimoto N, Saito H, Hayakawa T. The production of tissue inhibitors of metalloproteinases (TIMPs) in megakaryopoiesis: Possible role of platelet- and megakar. Br J Haematol 1997; 99: 181-9.
26. Santos-Martinez MJ, Medina C, Jurasz P, Radomski MW. Role of metalloproteinases in platelet function. Thromb Res 2007; doi: 10.1016/j.thromres.2007.06.002.
27. Pirard B. Insight into the structural determinants for selective inhibition of matrix metalloproteinases. Drug Discov Today 2007; 12: 640-6.
28. Chung AWY, Jurasz P, Hollenberg MD, Radomski MW. Mechanisms of action of proteinase-activated receptor agonists on human platelets. Br J Pharmacol 2002; 135: 1123-32.